Article Text

Download PDFPDF
Long term prognosis of children born to lupus patients
  1. A Murashima1,2,
  2. T Fukazawa2,
  3. M Hirashima2,
  4. Y Takasaki2,
  5. M Oonishi3,
  6. S Niijima3,
  7. Y Yamashiro3,
  8. A Yamataka4,
  9. T Miyano4,
  10. H Hashimoto2
  1. 1Department of Maternal Medicine, National Centre for Child Health and Development, Tokyo, Japan
  2. 2Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan
  3. 3Department of Paediatrics, Juntendo University School of Medicine, Tokyo, Japan
  4. 4Department of Paediatric Surgery, Juntendo University School of Medicine, Tokyo, Japan
  1. Correspondence to:
    Dr A Murashima
    Department of Maternal Medicine, National Centre for Child Health and Development, 2-10-1 Okura Setagaya-ku, Tokyo, 157-8535 Japan; murasima-ancchd.go.jp

Abstract

Objective: To determine the long term prognosis of children of patients with systemic lupus erythematosus (SLE).

Methods: Children of patients with SLE were invited to attend our clinic for physical examination and laboratory tests. A total of 195 children (aged 4 months to 26 years; male = 82, female = 113) were examined in 1991, 1995, 1997, and 1998.

Results: Two cases were diagnosed as SLE at the first visit and were excluded from the second visit. A significantly higher percentage (52/195 (27%)) of patients were positive for antinuclear antibodies (ANA) at a cut off serum dilution of 1/40 compared with controls (4/57 (7%)). ANA were detected more frequently in female subjects than in men (p<0.05). Forty four subjects were examined on more than two occasions. Nine of the 10 patients who were positive for ANA at the second visit were girls aged 4–8 years. The incidence of anti-DNA and antiphospholipid antibodies in children of patients with SLE was similar to that in the controls.

Conclusions: The finding that children, especially girls, born to maternal lupus patients had a high positive rate for ANA suggests that a genetic factor is involved in SLE pathogenesis. Longitudinal observation of these patients may provide important clinical information and clues to the pathogenesis of SLE.

  • systemic lupus erythematosus
  • children
  • antinuclear antibodies
  • prognosis
  • ANA, antinuclear antibodies
  • CL, cardiolipin
  • ELISA, enzyme linked immunosorbent assay
  • ENA, extractable antinuclear antigen
  • GP, glycoprotein
  • SLE, systemic lupus erythematosus

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes